Neurohormonal and metabolic effects of medetomidine compared with xylazine in healthy cats.
The purpose of this study was to investigate and compare the effects of medetomidine and xylazine on some neurohormonal and metabolic variables in healthy cats. Five cats were used repeatedly in each of 11 groups, which were injected intramuscularly with physiological saline solution (control), 20, 40, 80, 160, and 320 microg/kg of medetomidine, and 0.5, 1, 2, 4, and 8 mg/kg of xylazine. Blood samples were taken over 24 h from the jugular vein for determination of plasma glucose, insulin, cortisol, epinephrine, norepinephrine, glucagon, and nonesterified fatty acid concentrations. Both medetomidine and xylazine induced remarkable hyperglycemia that was dose-dependent except for the response to medetomidine from 0 to 3 h. Both agents suppressed epinephrine and norepinephrine release but not in a dose-dependent manner at the tested dosages. Both agents inhibited insulin release and lipolysis, with similar potency, and tended to suppress cortisol release. The glucagon levels did not change significantly in any of the groups. These results suggest that the effects of medetomidine and xylazine on glucose metabolism and catecholamine release may not be due only to the actions mediated by alpha2-adrenoceptors.
Kanda
Teppei
T
Laboratory of Veterinary Internal Medicine, Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, Koyama-Minami 4-101, Tottori 680-8553, Japan.
Hikasa
Yoshiaki
Y
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D019540:Area Under Curve; D002415:Cats / Q000097:blood / Q000378:metabolism*; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood; D005947:Glucose / Q000378:metabolism; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood; D008297:Male; D020926:Medetomidine / Q000494:pharmacology*; D009638:Norepinephrine / Q000097:blood; D011897:Random Allocation; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D014991:Xylazine / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011942:Receptors, Adrenergic, alpha; D014991:Xylazine; D005934:Glucagon; D005947:Glucose; D020926:Medetomidine; D006854:Hydrocortisone; D009638:Norepinephrine; D004837:Epinephrine